Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Neoplasms 2Lung Neoplasms 2Gliosarcoma 2Glioblastoma 2Carcinoma, Renal Cell 2Breast Neoplasms 2Uterine Cervical Neoplasms 1Tuberculosis, Pulmonary 1Tongue Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Salivary Gland Neoplasms 1Rhabdoid Tumor 1Rectal Neoplasms 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Nasopharyngeal Neoplasms 1Multiple Myeloma 1Mouth Neoplasms 1Lymphoma, Large B-Cell, Diffuse 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Head and Neck Neoplasms 1HER2-positive Breast Cancer 1Esthesioneuroblastoma, Olfactory 1Endometrial Neoplasms 1Colonic Neoplasms 1Chordoma 1Breast Neoplasms, Male 1

Interventions

alfatide II 1Fluorodeoxyglucose F18 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Tuberculosis, Pulmonary × Fluorodeoxyglucose F18 × Clear all
NCT02481726 2015-06-25

68Ga-AlfatideII for the Differential Diagnosis of of Lung Cancer and Lung Tuberculosis by PET/CT

Xijing Hospital

Phase 1/2 Completed
31 enrolled
Thoracic

Lung Neoplasms, Tuberculosis, Pulmonary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡